Madrigal Pharmaceuticals, Inc.
Public
MDGL
SectorHealthcare
CountryUnited States
Market cap12.17B
Madrigal Pharmaceuticals, Inc.: A biopharmaceutical company focused on the development of novel therapeutics for non-alcoholic steatohepatitis (NASH).
